Catalent
CTLT
#1736
Rank
โ‚น1.035 T
Marketcap
โ‚น5,703
Share price
0.00%
Change (1 day)
20.73%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น553.94 Billion

According to Catalent's latest financial reports the company's total liabilities are โ‚น553.94 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚น505.98 B11.77%
2022-06-30โ‚น452.69 B25.82%
2021-06-30โ‚น359.80 B11.21%
2020-06-30โ‚น323.52 B20.46%
2019-06-30โ‚น268.57 B13.92%
2018-06-30โ‚น235.75 B33.6%
2017-06-30โ‚น176.46 B6.48%
2016-06-30โ‚น165.72 B4.07%
2015-06-30โ‚น159.24 B-23.3%
2014-06-30โ‚น207.61 B3.81%
2013-06-30โ‚น199.99 B3.24%
2012-06-30โ‚น193.71 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Supernus Pharmaceuticals
SUPN
โ‚น33.24 B-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚น48.47 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น664.57 B 19.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
โ‚น28.86 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA